Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

CREATE Wellness: A multi-component behavioral intervention for patients not responding to traditional Cardiovascular disease management.

Miller-Rosales C, Sterling SA, Wood SB, Ross T, Makki M, Zamudio C, Kane IM, Richardson MC, Samayoa C, Charvat-Aguilar N, Lu WY, Vo M, Whelan K, Uratsu CS, Grant RW.

Contemp Clin Trials Commun. 2017 Oct 4;8:140-146. doi: 10.1016/j.conctc.2017.10.001. eCollection 2017 Dec.

2.

Influence of Language and Culture in the Primary Care of Spanish-Speaking Latino Adults with Poorly Controlled Diabetes: A Qualitative Study.

Zamudio CD, Sanchez G, Altschuler A, Grant RW.

Ethn Dis. 2017 Dec 7;27(4):379-386. doi: 10.18865/ed.27.4.379. eCollection 2017 Fall.

3.

Association between prepregnancy obesity and metabolic risk in Chilean premenopausal women 10 y postpartum.

Garmendia ML, Zamudio C, Araya M, Kain J.

Nutrition. 2017 Jun;38:20-27. doi: 10.1016/j.nut.2017.01.003. Epub 2017 Jan 12.

PMID:
28526378
4.

Design and use of mouse control DNA for DNA biomarker extraction and PCR detection from urine: Application for transrenal Mycobacterium tuberculosis DNA detection.

Bordelon H, Ricks KM, Pask ME, Russ PK, Solinas F, Baglia ML, Short PA, Nel A, Blackburn J, Dheda K, Zamudio C, Cáceres T, Wright DW, Haselton FR, Pettit AC.

J Microbiol Methods. 2017 May;136:65-70. doi: 10.1016/j.mimet.2017.02.010. Epub 2017 Mar 9.

5.

Cost-effectiveness of active case-finding of household contacts of pulmonary tuberculosis patients in a low HIV, tuberculosis-endemic urban area of Lima, Peru.

Shah L, Rojas M, Mori O, Zamudio C, Kaufman JS, Otero L, Gotuzzo E, Seas C, Brewer TF.

Epidemiol Infect. 2017 Apr;145(6):1107-1117. doi: 10.1017/S0950268816003186. Epub 2017 Feb 6.

PMID:
28162099
6.

Xpert MTB/RIF Assay Shows Faster Clearance of Mycobacterium tuberculosis DNA with Higher Levels of Rifapentine Exposure.

Jayakumar A, Savic RM, Everett CK, Benator D, Alland D, Heilig CM, Weiner M, Friedrich SO, Martinson NA, Kerrigan A, Zamudio C, Goldberg SV, Whitworth WC, Davis JL, Nahid P.

J Clin Microbiol. 2016 Dec;54(12):3028-3033. Epub 2016 Oct 12.

7.

Feasibility and Operational Performance of Tuberculosis Detection by Loop-Mediated Isothermal Amplification Platform in Decentralized Settings: Results from a Multicenter Study.

Gray CM, Katamba A, Narang P, Giraldo J, Zamudio C, Joloba M, Narang R, Paramasivan CN, Hillemann D, Nabeta P, Amisano D, Alland D, Cobelens F, Boehme CC.

J Clin Microbiol. 2016 Aug;54(8):1984-91. doi: 10.1128/JCM.03036-15. Epub 2016 May 18.

8.

Manual MGIT™ system for the detection of Mycobacterium tuberculosis: insights from a high TB burden setting.

Quispe R, Valle GA, Huapaya JA, Novoa I, Giraldo J, Caceres T, Gotuzzo E, Zamudio C, Seas C.

Int J Tuberc Lung Dis. 2016 May;20(5):605-10. doi: 10.5588/ijtld.15.0489.

PMID:
27084813
9.

Implementation of a stepped-wedge cluster randomized design in routine public health practice: design and application for a tuberculosis (TB) household contact study in a high burden area of Lima, Peru.

Shah L, Rojas M, Mori O, Zamudio C, Kaufman JS, Otero L, Gotuzzo E, Seas C, Brewer TF.

BMC Public Health. 2015 Jun 26;15:587. doi: 10.1186/s12889-015-1883-2.

10.

Public transportation and tuberculosis transmission in a high incidence setting.

Zamudio C, Krapp F, Choi HW, Shah L, Ciampi A, Gotuzzo E, Heymann J, Seas C, Brewer TF.

PLoS One. 2015 Feb 23;10(2):e0115230. doi: 10.1371/journal.pone.0115230. eCollection 2015.

11.

[Resistance to second-line anti-tuberculosis drugs among peruvian multidrug resistant Mycobacterium tuberculosis strains].

Barletta F, Zamudio C, Rigouts L, Seas C.

Rev Peru Med Exp Salud Publica. 2014 Oct-Dec;31(4):676-82. Spanish.

12.

Geographic predictors of primary multidrug-resistant tuberculosis cases in an endemic area of Lima, Peru.

Shah L, Choi HW, Berrang-Ford L, Henostroza G, Krapp F, Zamudio C, Heymann SJ, Kaufman JS, Ciampi A, Seas C, Gotuzzo E, Brewer TF.

Int J Tuberc Lung Dis. 2014 Nov;18(11):1307-14. doi: 10.5588/ijtld.14.0011.

PMID:
25299862
13.

Knowledge about HIV prevention and transmission among recently diagnosed tuberculosis patients: a cross sectional study.

Ugarte-Gil C, Ponce M, Zamudio C, Canaza L, Samalvides F, Seas C.

BMC Public Health. 2013 Dec 28;13:1237. doi: 10.1186/1471-2458-13-1237.

14.

Association of major depressive episode with negative outcomes of tuberculosis treatment.

Ugarte-Gil C, Ruiz P, Zamudio C, Canaza L, Otero L, Kruger H, Seas C.

PLoS One. 2013 Jul 29;8(7):e69514. doi: 10.1371/journal.pone.0069514. Print 2013.

15.

A diagnostic accuracy study of Xpert®MTB/RIF in HIV-positive patients with high clinical suspicion of pulmonary tuberculosis in Lima, Peru.

Carriquiry G, Otero L, González-Lagos E, Zamudio C, Sánchez E, Nabeta P, Campos M, Echevarría J, Seas C, Gotuzzo E.

PLoS One. 2012;7(9):e44626. doi: 10.1371/journal.pone.0044626. Epub 2012 Sep 7.

16.

Additional evidence to support the phasing-out of treatment category II regimen for pulmonary tuberculosis in Peru.

Ponce M, Ugarte-Gil C, Zamudio C, Krapp F, Gotuzzo E, Seas C.

Trans R Soc Trop Med Hyg. 2012 Aug;106(8):508-10. doi: 10.1016/j.trstmh.2012.05.008. Epub 2012 Jun 26.

PMID:
22742941
17.

Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis.

Vassall A, van Kampen S, Sohn H, Michael JS, John KR, den Boon S, Davis JL, Whitelaw A, Nicol MP, Gler MT, Khaliqov A, Zamudio C, Perkins MD, Boehme CC, Cobelens F.

PLoS Med. 2011 Nov;8(11):e1001120. doi: 10.1371/journal.pmed.1001120. Epub 2011 Nov 8.

18.

High prevalence of primary multidrug resistant tuberculosis in persons with no known risk factors.

Otero L, Krapp F, Tomatis C, Zamudio C, Matthys F, Gotuzzo E, Van der Stuyft P, Seas C.

PLoS One. 2011;6(10):e26276. doi: 10.1371/journal.pone.0026276. Epub 2011 Oct 27.

19.

Self-reported risks for multiple-drug resistance among new tuberculosis cases: implications for drug susceptibility screening and treatment.

Brewer TF, Choi HW, Seas C, Krapp F, Zamudio C, Shah L, Ciampi A, Heymann SJ, Gotuzzo E.

PLoS One. 2011;6(10):e25861. doi: 10.1371/journal.pone.0025861. Epub 2011 Oct 14.

20.

A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay.

Blakemore R, Nabeta P, Davidow AL, Vadwai V, Tahirli R, Munsamy V, Nicol M, Jones M, Persing DH, Hillemann D, Ruesch-Gerdes S, Leisegang F, Zamudio C, Rodrigues C, Boehme CC, Perkins MD, Alland D.

Am J Respir Crit Care Med. 2011 Nov 1;184(9):1076-84. doi: 10.1164/rccm.201103-0536OC.

21.

[Abdominal and gastrointestinal symptoms of Dengue fever. Analysis of a cohort of 8559 patients].

Ramos-De La Medina A, Remes-Troche JM, González-Medina MF, Anitúa-Valdovinos Mdel M, Cerón T, Zamudio C, Díaz-Vega A.

Gastroenterol Hepatol. 2011 Apr;34(4):243-7. doi: 10.1016/j.gastrohep.2011.01.012. Epub 2011 Apr 6. Spanish.

PMID:
21474206
22.

[Fructose intolerance in patients with irritable bowel syndrome: a case-control study].

Reyes-Huerta JU, de la Cruz-Patiño E, Ramírez-Gutiérrez de Velasco A, Zamudio C, Remes-Troche JM.

Rev Gastroenterol Mex. 2010 Oct-Dec;75(4):405-11. Spanish.

PMID:
21169107
23.

Clinical prediction rule for stratifying risk of pulmonary multidrug-resistant tuberculosis.

Martínez D, Heudebert G, Seas C, Henostroza G, Rodriguez M, Zamudio C, Centor RM, Herrera C, Gotuzzo E, Estrada C.

PLoS One. 2010 Aug 11;5(8):e12082. doi: 10.1371/journal.pone.0012082.

24.

Staphylococcus aureus TargetArray: comprehensive differential essential gene expression as a mechanistic tool to profile antibacterials.

Xu HH, Trawick JD, Haselbeck RJ, Forsyth RA, Yamamoto RT, Archer R, Patterson J, Allen M, Froelich JM, Taylor I, Nakaji D, Maile R, Kedar GC, Pilcher M, Brown-Driver V, McCarthy M, Files A, Robbins D, King P, Sillaots S, Malone C, Zamudio CS, Roemer T, Wang L, Youngman PJ, Wall D.

Antimicrob Agents Chemother. 2010 Sep;54(9):3659-70. doi: 10.1128/AAC.00308-10. Epub 2010 Jun 14.

25.

A Staphylococcus aureus fitness test platform for mechanism-based profiling of antibacterial compounds.

Donald RG, Skwish S, Forsyth RA, Anderson JW, Zhong T, Burns C, Lee S, Meng X, LoCastro L, Jarantow LW, Martin J, Lee SH, Taylor I, Robbins D, Malone C, Wang L, Zamudio CS, Youngman PJ, Phillips JW.

Chem Biol. 2009 Aug 28;16(8):826-36. doi: 10.1016/j.chembiol.2009.07.004.

26.

Oxacillin-resistant and multidrug-resistant Staphylococcus aureus in Lima, Peru.

Seas C, Hernandez K, Ramos R, Bazan E, Rodriguez I, Torres A, Zamudio C, Gotuzzo E.

Infect Control Hosp Epidemiol. 2006 Feb;27(2):198-200. Epub 2006 Feb 8.

PMID:
16465640
27.

Genome-wide operon prediction in Staphylococcus aureus.

Wang L, Trawick JD, Yamamoto R, Zamudio C.

Nucleic Acids Res. 2004 Jul 13;32(12):3689-702. Print 2004.

28.

A genome-wide strategy for the identification of essential genes in Staphylococcus aureus.

Forsyth RA, Haselbeck RJ, Ohlsen KL, Yamamoto RT, Xu H, Trawick JD, Wall D, Wang L, Brown-Driver V, Froelich JM, C KG, King P, McCarthy M, Malone C, Misiner B, Robbins D, Tan Z, Zhu Zy ZY, Carr G, Mosca DA, Zamudio C, Foulkes JG, Zyskind JW.

Mol Microbiol. 2002 Mar;43(6):1387-400.

Supplemental Content

Loading ...
Support Center